Beriplex® P/N (Kcentra) + Fresh frozen plasma
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Reversal of Coagulopathy
Conditions
Reversal of Coagulopathy
Trial Timeline
Feb 1, 2009 → Feb 1, 2013
NCT ID
NCT00803101About Beriplex® P/N (Kcentra) + Fresh frozen plasma
Beriplex® P/N (Kcentra) + Fresh frozen plasma is a phase 3 stage product being developed by CSL for Reversal of Coagulopathy. The current trial status is completed. This product is registered under clinical trial identifier NCT00803101. Target conditions include Reversal of Coagulopathy.
What happened to similar drugs?
2 of 2 similar drugs in Reversal of Coagulopathy were approved
Approved (2) Terminated (0) Active (0)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00803101 | Phase 3 | Completed |
| NCT00708435 | Phase 3 | Completed |
Competing Products
3 competing products in Reversal of Coagulopathy
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Sugammadex 2 mg/kg + Sugammadex 4 mg/kg + Sugammadex 16 mg/kg + Neostigmine + Glycopyrrolate + Rocuronium + Vecuronium | Merck | Approved | 43 |
| Sugammadex + Neostigmine | Merck | Approved | 43 |
| Beriplex | CSL | Phase 2 | 31 |